CA
NZ
UK
AU
IND
US
● Health care hit a record high as investors left AI and chip stocks.
● Third-quarterEarnings Per Shareof $7.48 beat the $6.61 estimate.
Key Highlights● McKesson rose 1.40% to close at $994.58 on October 30, 2026.● Morgan Stanley raised its target to $1,207 from $977.● It kept an Overweight rating.● Fiscal second-quarter results are due on November 4.Why did McKesson (NYSE:MCK) gain on one of the worst …
● Full-year adjusted EPS guidance rose to a range of $13.95 to $13.99.
● AdjustedEarningsof $0.54 a share beat the $0.47 estimate.
● Health care was one of six S&P 500 sectors to finish higher.
● The company authorized up to $1 billion in share repurchases.
AdjustedEarnings Per Sharecame in at $20.07, compared with the $16.42 that had been expected, a gap of more than $3.60. Revenue growth on that scale is striking for a mature biotech and suggests the company's main growth drivers delivered a strong quarter. Investors had …
Twist manufactures synthetic DNA using a silicon-based platform that lets it write genetic material at scale. Its products include synthetic genes, oligonucleotide pools and tools for sequencing preparation, and it serves customers in drug discovery, academic research, agriculture and industrial biology. Over the past …
When one company in an industry reports disappointing results, investors often reassess others in the same field, reasoning that customer spending patterns orDemandmay affect peers too. That can pull down related stocks even when they have reported nothing new. Whether Illumina's shortfall reflects conditions …
Please wait processing your request...